Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Bioabsorbable Stents Market In 2029?

Over the recent years, the bioabsorbable stents market has experienced significant growth. The market size is projected to escalate from $0.37 billion in 2024 to $0.41 billion in 2025, showing a compound annual growth rate (CAGR) of 9.9%. Factors contributing to the growth during the historic period include an increase in cardiovascular diseases, a burgeoning demand for minimally invasive procedures, heightened awareness about bioabsorbable stents, growing disposable incomes, and increased investments in the industry.

What Growth Rate Is Forecasted for the Bioabsorbable Stents Market by 2029?

The market for bioabsorbable stents is predicted to experience substantial growth in the coming years, expanding to a value of $0.59 billion by 2029 with a compound annual growth rate (CAGR) of 9.8%. This growth throughout the forecasted period can be linked to a range of factors including expanded clinical applications, customization, personalization, global market expansion, and the preference of patients for this option. Notable trends for this period encompass advancements in bioabsorbable materials, clinical progression, data research, hybrid stent designs, extended absorption periods and collaboration and partnerships.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3269&type=smp

Which Key Companies Are Shaping the Future of the Bioabsorbable Stents Market?

Major companies operating in the bioabsorbable stents market include Abbott Laboratories, REVA Medical Inc., Elixir Medical Corporation, Biotronik SE & Co. KG, Amaranth Medical Inc., Zorion Medical Inc., Tepha Inc., S3V Vascular Technologies, ICON Interventional Systems Inc., Arterius Limited, Microport Scientific Corporation, Meril Life Sciences Pvt. Ltd., Medlogics Device Corporation, B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard Inc., Stentys SA, Terumo Corporation, OrbusNeich, Arterial Remodeling Technologies, Cardionovum GmbH, Envision Scientific Pvt Ltd., Eurocor GmbH, Hexacath, Kyoto Medical Planning Co. Ltd., Lifetech Scientific (Shenzhen) Co. Ltd., Manli Cardiology Limited, Medtronic Inc., QualiMed Innovative Medizinprodukte GmbH, Sahajanand Medical Technologies Pvt. Ltd., Sinomed, Surmodics Inc., Translumina Therapeutics, Vascular Concepts Limited, Xenogenics Corporation

Which Factors Are Driving Demand in the Bioabsorbable Stents Industry?

The surge in heart failure incidents is expected to boost the bioabsorbable stents market. Heart failure is a health complication marked by the diminished competency of the heart muscle to pump blood effectively, leading to fluid overload in the body. Bioabsorbable stents can be utilized in dealing with heart failure to improve heart functionality and alleviate its symptoms. For instance, the Heart and Stroke Foundation of Canada, an authoritative Canadian organization providing details on stroke, heart ailment, surgeries, and treatments, reported in February 2022 that there are currently 750,000 people diagnosed with heart failure. It also documented an annual increase of 100,000 new heart-failure patients – a condition that has no cure. Predictions suggest that by 2030, healthcare costs linked to heart failure in Canada are expected to skyrocket to an annual $2.8 billion. Hence, the escalating number of heart-failure cases will fuel the growth of the bioabsorbable stents market in the coming years.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3269&type=smp

How Is the Bioabsorbable Stents Market Segmented by Several Divisions?

The bioabsorbable stents market covered in this report is segmented –

1) By Product Type: Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents

2) By Absorption Rate: Slow- Absorption Stents, Fast- Absorption Stents

3) By Applications: Coronary Artery Diseases, Peripheral Artery Diseases

Subsegments:

1) By Polymer-Based Bioabsorbable Stents: PLGA (Poly(Lactic-Co-Glycolic Acid)) Stents, PGA (Polyglycolic Acid) Stents, PLLA (Poly(L-Lactic Acid)) Stents, Other Biodegradable Polymer Stents

2) By Metal-Based Bioabsorbable Stents: Magnesium-Based Stents, Iron-Based Stents, Zinc-Based Stents, Other Metal-Based Bioabsorbable Stents

What are the Emerging Market Trends Driving the Growth of the Bioabsorbable Stents Industry?

The leading enterprises in the bioabsorbable stents market are concentrating on the creation of innovative technologies, such as the Newest Generation of Bioresorbable Cardiac Stent, to enhance their market profit margins. The newest generation of bioresorbable cardiac stents are sophisticated medical devices specifically made from biodegradable materials and constructed for use in treating coronary artery disease, that disappear over a period of time after fulfilling their purpose of maintaining the artery’s functionality. For instance, MicroPort Scientific Corporation, a medical equipment producing company based in China, recently gained market endorsement for the globally first, fully bioresorbable cardiac stent of the next generation from the National Medical Products Administration (NMPA) in China, in July 2024. Firesorb, the new product developed by MicroPort Scientific Corporation, is planned to completely vanish within the span of three years, considerably cutting down the risks of long-term issues like thrombosis. Clinical examinations involving 1,468 patients have exhibited remarkable outcomes, including a minute rate of thrombosis at 0.32% and an exceedingly low target lesion failure rate of a mere 4.3% over a span of four years. Its state-of-the-art thin strut design and superior endothelial coverage in comparison to the prior stent generations has been commended by top medical professionals.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

Which Regions Are Driving Growth in the Bioabsorbable Stents Market?

North America was the largest region in the bioabsorbable stents market in 2023. Western Europe was the second-largest region in the bioabsorbable stents market report. The regions covered in the bioabsorbable stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3269

This Report Delivers Insight On:

1. How big is the bioabsorbable stents market, and how is it changing globally?

2. Who are the major companies in the bioabsorbable stents market, and how are they performing?

3. What are the key opportunities and risks in the bioabsorbable stents market right now?

4. Which products or customer segments are growing the most in the bioabsorbable stents market?

5. What factors are helping or slowing down the growth of the bioabsorbable stents market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model